Post-transplant Lymphoproliferative Disorder
📧 Sign up to get email alerts when something new happens for Post-transplant Lymphoproliferative Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-03-12Clinical Trial Update: Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas [Phase 2]
Phase 2 trial update of cellular immunotherapy targeting EBV in viral-induced cancers including various lymphomas; the study is terminated w…
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma [Phase 2]
Phase 2 trial evaluating rituximab in patients undergoing donor peripheral blood stem cell transplantation for relapsed or refractory B-cell…
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders [Phase 2]
A Phase 2 trial evaluating the combination of bortezomib and rituximab for post-transplant lymphoproliferative disorders was terminated, wit…
-
CLINICAL_TRIALS withdrawal · 2017-03-22Clinical Trial Update: Single Agent Obinutuzumab in Relapsed/Refractory Post-Transplant Lymphoproliferative Disorder (PTLD) [Phase 2]
A Phase 2 trial evaluating single-agent obinutuzumab for relapsed/refractory Post-transplant Lymphoproliferative Disorder has been withdrawn…
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: aCGH Impacts Survival in Plasma Cell PTLD
A clinical trial update reports that array-based comparative genomic hybridization (aCGH) testing may influence survival outcomes in patient…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-04-13Clinical Trial Update: EBV Infection as a Risk Factor for PTLD in Pediatric and Adult Renal Transplant Recipients
This completed clinical trial evaluated Epstein-Barr virus infections as a risk factor for post-transplant lymphoproliferative disorder in p…
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation [Phase 1]
Phase 1 trial evaluating the combination of Beta-Glucan and Rituximab in young patients with relapsed or progressive leukemia or lymphoma, i…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorder [Phase 1, Phase 2]
A Phase 1/2 trial evaluating Yttrium-90 ibritumomab tiuxetan in combination with rituximab for post-transplant lymphoproliferative disorder …
-
CLINICAL_TRIALS research · 2013-01-17Clinical Trial Update: Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Lymphoma [Phase 1]
Phase 1 trial evaluating a radiolabeled monoclonal antibody with or without peripheral stem cell transplantation in children with recurrent …
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: Relationship Between EBV and PTLD
A pediatric heart transplant trial studying the relationship between Epstein-Barr virus and post-transplant lymphoproliferative disorder has…
-
CLINICAL_TRIALS trial_result · 2011-10-25Clinical Trial Update: Sequential Treatment of CD20-positive Posttransplant Lymphoproliferative Disorder (PTLD) [Phase 2]
Phase 2 trial update on sequential treatment for CD20-positive post-transplant lymphoproliferative disorder, with the study status listed as…
-
CLINICAL_TRIALS trial_result · 2010-01-13Clinical Trial Update: Detection and Cytotoxic T Lymphocyte Therapy of Post-Transplant Lymphoproliferative Disorder After Liver Transplant [Phase 1]
Phase 1 clinical trial evaluating cytotoxic T lymphocyte therapy for post-transplant lymphoproliferative disorder after liver transplantatio…